162 How often do physicians follow national guidelines for the diagnosis of hypertensive diseases of pregnancy? 
OBJECTIVE:
The formulation of an accurate diagnosis influences delivery timing, and thus impacts pregnancy outcomes.It remains unclear how often physicians in clinical practice follow our national organization's diagnostic criteria recommendations for hypertensive diseases of pregnancy (HDP). Our aim was to compare HDP diagnoses made by clinicians to those generated by experts who reviewed charts and adjudicated diagnoses.Further, we reviewed the clinical implications of the diagnoses made on timing of delivery. STUDY DESIGN: We conducted a secondary analysis of a multicenter prospective cohort study designed to evaluate serum PlGF in predicting adverse pregnancy outcome in women who presented with signs or symptoms of preeclampsia (PE). The study was performed in 24 centers in the US and Canada. The diagnosis and management criteria used were prior to the Hypertension in Pregnancy Task Force Guidelines publication. We reviewed patients who received the final diagnosis of preeclampsia (mild or severe), atypical preeclampsia, chronic hypertension, gestational hypertension (mild or severe), HELLP, eclampsia and those who remained non hypertensive.We then compared the diagnosis made by managing physicians to that adjudicated by experts who reviewed the charts. We also valuated the impact of asynchronous diagnosis on gestational age at delivery recommendations. RESULTS: 869 patients were included,of which 404 (46%) had a discordant diagnosis between investigator and adjudicators (figure 1). These differences in diagnoses would have affected delivery recommendations for 314 patients. All 31 patients undergoing immediate delivery per the investigator diagnosis, received diagnoses by the adjudicators that did not warrant immediate delivery (figure 2). On the other hand, all 25 patients that had a diagnosis consistent with expectant management by the investigators, would have been delivered earlier based on adjudicated diagnosis. Furthermore 65% of patients with a clinician diagnosis that recommended delivery at 37-39 weeks would have been delivered earlier by the expert adjudicator.
CONCLUSION:
The implications of lack of compliance with guideline recommendations for diagnosis and management of HDP amongst clinicians are concerning since they could lead to adverse pregnancy outcome. Future studies are needed to investigate the reasons for non-adherence with guideline recommendations in clinical practice.
OBJECTIVE:
To compare measurement of blood loss using the quantitative Triton system (Gauss Surgical, Inc., Los Altos, CA) with other measures of blood loss in women who underwent cesarean delivery. STUDY DESIGN: We included all women scheduled for cesarean delivery at our facility. Intraoperative blood loss was measured using the Triton, which was masked to the clinical team, as well as estimated by the surgeon (EBL). The relation between the two methods (Triton and EBL) and post-op Hgb as well as DHgb (post-op minus pre-op Hgb) was determined using bivariate and multivariate linear regressions. Triton measurement and EBL were compared between women with DHgb in the upper quartile (cases) versus all other quartiles (control). Prediction of DHgb in the upper quartile was also evaluated for each method, and the area under the ROC curves (AUCs) was compared. McNemar and Mann-Whitney tests were used. RESULTS: The trial enrolled 109 patients. The mean blood loss estimated by Triton was significantly lower than that estimated by EBL (437.5 AE 267.8 vs. 839.9 AE 244.7 mL, P<.0001). By bivariate analysis, DHgb correlated with Triton estimate but not EBL (Figure) . 30 patients had DHgb in the upper quartile (DHgb ! 2 g/dL). There was significant difference in the Triton blood loss measurement between cases and controls, but no difference in EBL (Table) . Triton, but not EBL, was predictive of DHgb ! 2 g/dL (Triton ROC AUC:
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